BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2347920)

  • 1. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.
    Bourdi M; Larrey D; Nataf J; Bernuau J; Pessayre D; Iwasaki M; Guengerich FP; Beaune PH
    J Clin Invest; 1990 Jun; 85(6):1967-73. PubMed ID: 2347920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
    Bourdi M; Gautier JC; Mircheva J; Larrey D; Guillouzo A; Andre C; Belloc C; Beaune PH
    Mol Pharmacol; 1992 Aug; 42(2):280-5. PubMed ID: 1513326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-peptide antibody targeted to a specific region of rat cytochrome P-450IA2 inhibits enzyme activity.
    Edwards RJ; Singleton AM; Murray BP; Sesardic D; Rich KJ; Davies DS; Boobis AR
    Biochem J; 1990 Mar; 266(2):497-504. PubMed ID: 1690539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.
    Beaune P; Dansette PM; Mansuy D; Kiffel L; Finck M; Amar C; Leroux JP; Homberg JC
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):551-5. PubMed ID: 3540968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.
    Berthou F; Flinois JP; Ratanasavanh D; Beaune P; Riche C; Guillouzo A
    Drug Metab Dispos; 1991; 19(3):561-7. PubMed ID: 1680620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydralazine-induced inactivation of cytochrome P450 enzymes in rat liver microsomes.
    Masubuchi Y; Horie T
    Drug Metab Dispos; 1998 Apr; 26(4):338-42. PubMed ID: 9531521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.
    Obermayer-Straub P; Strassburg CP; Manns MP
    Can J Gastroenterol; 2000 May; 14(5):429-39. PubMed ID: 10851284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope mapping of human CYP1A2 in dihydralazine-induced autoimmune hepatitis.
    Belloc C; Gauffre A; André C; Beaune PH
    Pharmacogenetics; 1997 Jun; 7(3):181-6. PubMed ID: 9241657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anti-cytochrome P4501A2 autoantibodies.
    Bourdi M; Tinel M; Beaune PH; Pessayre D
    Mol Pharmacol; 1994 Jun; 45(6):1287-95. PubMed ID: 8022422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.
    Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF
    J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.
    Dalekos GN; Makri E; Loges S; Obermayer-Straub P; Zachou K; Tsikrikas T; Schmidt E; Papadamou G; Manns MP
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):35-42. PubMed ID: 11782573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.
    Robin MA; Maratrat M; Le Roy M; Le Breton FP; Bonierbale E; Dansette P; Ballet F; Mansuy D; Pessayre D
    J Clin Invest; 1996 Sep; 98(6):1471-80. PubMed ID: 8823314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrosomal antibodies: what are they telling us?
    Watkins PB
    Hepatology; 1991 Feb; 13(2):385-7. PubMed ID: 1995447
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes.
    Wheeler CW; Park SS; Guenthner TM
    Mol Pharmacol; 1990 Nov; 38(5):634-43. PubMed ID: 2233699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new form of cytochrome P-450 responsible for mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline in human livers.
    Ubukata K; Ohi H; Kitada M; Kamataki T
    Cancer Res; 1992 Feb; 52(4):758-63. PubMed ID: 1737335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human anti-endoplasmic reticulum autoantibodies produced in aromatic anticonvulsant hypersensitivity reactions recognise rodent CYP3A proteins and a similarly regulated human P450 enzyme(s).
    Riley RJ; Smith G; Wolf CR; Cook VA; Leeder JS
    Biochem Biophys Res Commun; 1993 Feb; 191(1):32-40. PubMed ID: 8447835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7-Ethoxycoumarin and 7-ethoxyresorufin O-deethylase in human foetal and adult liver: studies with monoclonal antibodies.
    Pacifici GM; Park SS; Gelboin HV; Rane A
    Pharmacol Toxicol; 1988 Jul; 63(1):26-9. PubMed ID: 3261011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis.
    Kitteringham NR; Kenna JG; Park BK
    Br J Clin Pharmacol; 1995 Oct; 40(4):379-86. PubMed ID: 8554940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens.
    Obermayer-Straub P; Manns MP
    Mol Biol Rep; 1996; 23(3-4):235-42. PubMed ID: 9112234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.